glp 1 drug novo nordisk Details of failed studies cast pall on Nordisk's GLP-1 as Alzheimer's treatment The GLP-1 Race - VERUS

doi: 10.1016/j.ijsu.2015.08.001 Summary Keywords Hashimotos thyreoiditis, biochemical euthroidism, therapy, autoimmunity modulation, symptoms Citation Zhang H, Tong W, Zeng W, Luo H, Zhang L, Feng J, Xiao Y and Wang G (2025) Persistent symptoms in euthyroid Hashimotos thyroiditis: current hypotheses and emerging management strategies

Salama AA

Ishizawa J, Kojima K, Chachad D, Ruvolo P, Ruvolo V, Jacamo RO, Borthakur G, Mu H, Zeng Z, Tabe Y, Allen JE, Wang Z, Wencai M, Lee HC, Orlowski R, Sarbassov DD, Neelapu SS, McDonnell T, Miranda RN, Wang M, Kantarjian H, Konopleva M, Davis, RE, Andreeff M

Brand positioning of these products as supporting natural GLP-1 production represents their marketing claims and has not been evaluated by the FDA